Author

F. Mey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Karsan· 1 shared A. Y.-C. Mo· 1 shared D. Wood· 1 shared E. Willie· 1 shared G. B. Morin· 1 shared G. Duns· 1 shared H. Kincross· 1 shared H. Kwan· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Karsan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Loss of FBXO11 function establishes a stem cell program in acute myeloid leukemia through dysregulation of the mitochondrial LONP1

A. Y.-C. Mo, H. Kincross, X. Wang, L. Y.-T. Chang, G. Duns, F. Mey, Z. Zhu, H. Kwan, T. Lau, T. R. Docking, J. Tran, S. Colborne, S.-W. G. Cheng, S. Huang, N. Gharaee, , A. Karsan

This study identifies FBXO11 loss as a driver of AML by promoting a stem cell program through mitochondrial dysregulation.

bioRxiv · Sep 10, 2022 · PreprintCancer Biology